LABETALOL RMB, LABETALOL SXP, LABETALOL TLB (Southern Cross Pharma Pty Ltd)
Product name
LABETALOL RMB, LABETALOL SXP, LABETALOL TLB
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
248 working days (255)
Active ingredients
labetalol hydrochloride
Registration type
EOI
Indication
LABETALOL RMB, LABETALOL SXP, LABETALOL TLB (solution for injection) is indicated for the emergency treatment of severe hypertension when prompt and urgent reduction of blood pressure is essential.